Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
- Conditions
- Hodgkin´s Lymphoma
- First Posted Date
- 2006-01-31
- Last Posted Date
- 2011-07-29
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 65
- Registration Number
- NCT00284271
- Locations
- 🇩🇪
University of Cologne, Cologne, Germany
Fludarabine and Darbepoetin Alfa in Treating Older Patients With Chronic Lymphocytic Leukemia
- Conditions
- AnemiaChronic Lymphocytic Leukemia
- Interventions
- Biological: Fludarabine plus Darbopoetin
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2018-05-11
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 97
- Registration Number
- NCT00281892
- Locations
- 🇩🇪
Caritas - Krakenhaus Lebach, Lebach, Germany
🇩🇪I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen, Munich, Germany
🇩🇪Praxis fuer Haematologie und Interne Onkologie, Norderstedt, Germany
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
- Conditions
- Leukemia
- Interventions
- First Posted Date
- 2006-01-25
- Last Posted Date
- 2013-09-19
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 817
- Registration Number
- NCT00281918
- Locations
- 🇩🇪
Praxis Fur Hamatologie und Onkologie Ahaus, Ahaus, Germany
🇩🇪Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg, Augsburg, Germany
🇩🇪Onkologische Schwerpunktpraxis Bielefeld, Bielefeld, Germany
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabBiological: filgrastimRadiation: radiation therapy
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- German High-Grade Non-Hodgkin's Lymphoma Study Group
- Target Recruit Count
- 700
- Registration Number
- NCT00278408
- Locations
- 🇩🇪
Virngrund-Klinik Ellwangen, Ellwangen, Germany
🇩🇪Klinikum Bayreuth, Bayreuth, Germany
🇩🇪University Hospital Schleswig-Holstein - Kiel Campus, Kiel, Germany
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- German High-Grade Non-Hodgkin's Lymphoma Study Group
- Target Recruit Count
- 592
- Registration Number
- NCT00278421
- Locations
- 🇩🇪
Klinikum Lippe - Lemgo, Lemgo, Germany
🇩🇪Onkologische Schwerpunktpraxis, Wendlingen, Germany
🇩🇪Klinikum Frankfurt (Oder) GmbH, Frankfurt (Oder), Germany
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 375
- Registration Number
- NCT00276848
- Locations
- 🇩🇪
St. Marienhospital - Vechta, Vechta, Germany
🇩🇪Evangelisches Krankenhaus Essen Werden, Essen, Germany
🇩🇪Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- Biological: Rituximab
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 195
- Registration Number
- NCT00274989
- Locations
- 🇩🇪
HELIOS Klinikum Bad Saarow, Bad Saarow, Germany
🇩🇪Internistische Praxis - Arnstadt, Arnstadt, Germany
🇩🇪Klinikum Augsburg, Augsburg, Germany
Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- German CLL Study Group
- Target Recruit Count
- 825
- Registration Number
- NCT00275054
- Locations
- 🇦🇹
Universitaetsklinik fuer Innere Medizin I, Vienna, Austria
🇫🇷CHU Poitiers, Poitiers, France
🇩🇪St. Hedwig Krankenhaus, Berlin, Germany
HD12 for Advanced Stages
- Conditions
- Hodgkin´s Lymphoma
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2012-06-25
- Lead Sponsor
- University of Cologne
- Registration Number
- NCT00265031
HD11 for Intermediate Stages
- Conditions
- Hodgkin´s Lymphoma
- Interventions
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2011-08-04
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 1395
- Registration Number
- NCT00264953